Fast Urine 5-HIAA ELISA
5-HIAA (5-Hydroxyindoleacetic acid) is the main metabolite of serotonin. Urinary excretion of 5-HIAA is routinely used as a surrogate biomarker to diagnose and monitor carcinoid tumors. In the cerebrospinal fluid, low levels of 5-HIAA have been found to be associated with agressive behavior and suicide by violent means.
5-HIAA ELISA kit - Urine - Fast TrackRef: BA-E-1900
This 5-hydroxyindoleacetic acid (5-HIAA) ELISA kit is tailored for the rapid measurement of 5-HIAA in urine samples (specific protocols for CSF and plasma are available). Intended for in vitro diagnostics, this fast-track quantitative immunoassay can be performed within 3 hours.
||50 µl urine
|Samples/kit||40 samples in duplicate|
|Range||0 / 0.5 - 50 mg/l|
|Species reactivity||Reacts with all species|
Shipping info :
(for 1 kit)
|54.00€ , 5 days|
|Product information||Key steps||References||Technical support||Reviews|
5-HIAA ELISA kit - Urine - Fast-Track
|Description||In vitro diagnostics enzyme immunoassay (ELISA) for the fast determination of 5-HIAA in urine samples.
|Samples||50 µl urine|
|Cross specie-reactivity||React with all species|
|Standard range||0 / 0.5 - 50 mg/l|
No significant cross-reactivity was observed with 5-HIAA analogs such as Serotonin, 5-Hydroxy-DL-Tryptophan, Tryptamine, Melatonin, 5-Hydroxytryptamin, Vanillic mandelic acid and Homovanillic Acid.
|Assay time||3 hours|
|Storage||Store at 2-8°C for up to 6 months.|
|Datasheets||Instructions for use , Material safety datasheet|
|Sample collection & storage||
Spontaneous or 24-hour urine, collected in a bottle containing 10-15 mL of 6 M HCl. Storage: for longer periods (up to 6 months) at -20°C.
Sample predilution and methylation (30 min)
|ELISA||5-HIAA antiserum incubation (1 hour), revelation and read steps (90 min).|
|Detailed protocol||Download instructions for use|
- Beer TM et al. Acupuncture for Hot Flashes in Patients With Prostate Cancer. Urology. 2010 Nov;76(5):1182-8.
- Jackson LN et al. Development and Characterization of a Novel In vivo Model of Carcinoid Syndrome. Clin Cancer Res. 2009 Apr 15;15(8):2747-55.